| Dr Aaron Rockney Parry Ii, MD | |
|
830 Pennsylvania Ave, Suite 301, Charleston, WV 25302-3302 | |
| (304) 346-4455 | |
| (304) 346-4457 |
| Full Name | Dr Aaron Rockney Parry Ii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 830 Pennsylvania Ave, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982864799 | NPI | - | NPPES |
| 3810023350 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | MD40620 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trident Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Health Partners Pa | 1355334590 | 2 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
A new analysis has found that some second trimester markers for Down's syndrome that are detected by ultrasound are more telling than others. Published early online in Ultrasound in Obstetrics & Gynecology, the study's results will help adjust pregnant women's risks for having a child with the condition.
Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company's non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company's common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.
Nearly half of New Hampshire residents surveyed believe scientists adjust their findings to get the answers they want, and these people are significantly less likely to trust the Centers for Disease Control (CDC) as a source of information on the Zika virus, according to new research released by the Carsey School of Public Policy at the University of New Hampshire.
› Verified 1 days ago
| Entity Name | Womens Health Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659327567 PECOS PAC ID: 1355334590 Enrollment ID: O20040405001244 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
A new analysis has found that some second trimester markers for Down's syndrome that are detected by ultrasound are more telling than others. Published early online in Ultrasound in Obstetrics & Gynecology, the study's results will help adjust pregnant women's risks for having a child with the condition.
Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company's non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company's common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.
Nearly half of New Hampshire residents surveyed believe scientists adjust their findings to get the answers they want, and these people are significantly less likely to trust the Centers for Disease Control (CDC) as a source of information on the Zika virus, according to new research released by the Carsey School of Public Policy at the University of New Hampshire.
› Verified 1 days ago
| Entity Name | Obhg South Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538457361 PECOS PAC ID: 7012182504 Enrollment ID: O20111212000681 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
A new analysis has found that some second trimester markers for Down's syndrome that are detected by ultrasound are more telling than others. Published early online in Ultrasound in Obstetrics & Gynecology, the study's results will help adjust pregnant women's risks for having a child with the condition.
Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company's non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company's common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.
Nearly half of New Hampshire residents surveyed believe scientists adjust their findings to get the answers they want, and these people are significantly less likely to trust the Centers for Disease Control (CDC) as a source of information on the Zika virus, according to new research released by the Carsey School of Public Policy at the University of New Hampshire.
› Verified 1 days ago
| Entity Name | Uwh Of The Carolinas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639506470 PECOS PAC ID: 0042448169 Enrollment ID: O20210318002461 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
A new analysis has found that some second trimester markers for Down's syndrome that are detected by ultrasound are more telling than others. Published early online in Ultrasound in Obstetrics & Gynecology, the study's results will help adjust pregnant women's risks for having a child with the condition.
Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company's non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company's common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.
Nearly half of New Hampshire residents surveyed believe scientists adjust their findings to get the answers they want, and these people are significantly less likely to trust the Centers for Disease Control (CDC) as a source of information on the Zika virus, according to new research released by the Carsey School of Public Policy at the University of New Hampshire.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Rockney Parry Ii, MD 75 Springview Lane, Summerville, SC 29485-8154 Ph: (843) 832-5096 | Dr Aaron Rockney Parry Ii, MD 830 Pennsylvania Ave, Suite 301, Charleston, WV 25302-3302 Ph: (304) 346-4455 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
A new analysis has found that some second trimester markers for Down's syndrome that are detected by ultrasound are more telling than others. Published early online in Ultrasound in Obstetrics & Gynecology, the study's results will help adjust pregnant women's risks for having a child with the condition.
Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company's non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company's common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.
Nearly half of New Hampshire residents surveyed believe scientists adjust their findings to get the answers they want, and these people are significantly less likely to trust the Centers for Disease Control (CDC) as a source of information on the Zika virus, according to new research released by the Carsey School of Public Policy at the University of New Hampshire.
› Verified 1 days ago
Dr. Karinna Hope Andrews, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3110 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-388-2068 Fax: 304-388-2437 | |
Dr. Stephen Harold Bush, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-388-1515 Fax: 304-388-1570 | |
Dr. Stephen Harold Bush Ii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Courtney Dr, Charleston, WV 25304 Phone: 304-925-4200 Fax: 304-925-0483 | |
Ms. Lauren Nicole Becker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Courtney Dr, Charleston, WV 25304 Phone: 304-925-7600 | |
Jessica L Matheny, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Courtney Dr, Charleston, WV 25304 Phone: 304-925-7600 Fax: 304-925-5892 | |
Mr. Robert Todd Depond, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Suite 304, Charleston, WV 25302 Phone: 304-388-1552 | |
Dr. David W Thomas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Ste 402, Charleston, WV 25302 Phone: 304-343-5736 Fax: 304-343-5271 |